The former are expected pharmacological effects related to delayed gastric emptying and typically improve with continued use or dose adjustment
In conclusion, despite the clearly apparent therapeutic potential of MTs, their role is convoluted and context-dependent
Severe reactions, though rare, may include infection or allergic response at the injection site
Brukinsa, in combination with Genentechs Gazyva, is now authorized for the third-line treatment of relapsed or refractory follicular lymphoma (FL)
This shared pathophysiology has led to several medical guidelines on the management of MASLD/MASH strongly recommending the use of glucagon-like peptide-1 (GLP-1) receptor agonist-based therapies, alone or in combination with sodiumglucose cotransporter 2 (SGLT2) inhibitors, as first-line therapeutic options for individuals with type 2 diabetes and MASLD [5, 17]
However, the causative link between OS and neurodegeneration is not in the scope of this part as it focuses on the dysregulation of the GSH-based antioxidant network in the context of common neurodegenerative diseases: Parkinsons disease, Alzheimers disease [6]